"Crigler-Najjar Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A familial form of congenital hyperbilirubinemia transmitted as an autosomal recessive trait. It is characterized by icterus and brain damage caused by a glucuronyl transferase deficiency in the liver and faulty bilirubin conjugation.
    
			
			
				
				
					
						| Descriptor ID | D003414 | 
					
						| MeSH Number(s) | C16.320.565.300.281 C18.452.648.300.281 | 
					
						| Concept/Terms | Crigler-Najjar SyndromeCrigler-Najjar SyndromeCrigler Najjar Syndrome, Type 1Crigler-Najar SyndromeCrigler Najar SyndromeFamilial Nonhemolytic Unconjugated HyperbilirubinemiaHereditary Unconjugated HyperbilirubinemiaCrigler Najjar SyndromeCrigler-Najjar Syndrome, Type ICrigler Najjar Syndrome, Type I
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Crigler-Najjar Syndrome".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Crigler-Najjar Syndrome".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Crigler-Najjar Syndrome" by people in this website by year, and whether "Crigler-Najjar Syndrome" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2006 | 1 | 0 | 1 | 
| 2018 | 1 | 0 | 1 | 
| 2019 | 1 | 0 | 1 | 
| 2020 | 1 | 0 | 1 | 
| 2022 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Crigler-Najjar Syndrome" by people in Profiles.
						
					
								- 
								Aronson SJ, Junge N, Trabelsi M, Kelmemi W, Hubert A, Brigatti KW, Fox MD, de Knegt RJ, Escher JC, Ginocchio VM, Iorio R, Zhu Y, ?z?ay F, Rahim F, El-Shabrawi MHF, Shteyer E, Di Giorgio A, D'Antiga L, Mingozzi F, Brunetti-Pierri N, Strauss KA, Labrune P, Mrad R, Baumann U, Beuers U, Bosma PJ. Disease burden and management of Crigler-Najjar syndrome: Report of a world registry. Liver Int. 2022 07; 42(7):1593-1604. 
- 
								Strauss KA, Ahlfors CE, Soltys K, Mazareigos GV, Young M, Bowser LE, Fox MD, Squires JE, McKiernan P, Brigatti KW, Puffenberger EG, Carson VJ, Vreman HJ. Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier. Hepatology. 2020 06; 71(6):1923-1939. 
- 
								Dhawan A, Lawlor MW, Mazariegos GV, McKiernan P, Squires JE, Strauss KA, Gupta D, James E, Prasad S. Disease burden of Crigler-Najjar syndrome: Systematic review and future perspectives. J Gastroenterol Hepatol. 2020 Apr; 35(4):530-543. 
- 
								Mitchell E, Ranganathan S, McKiernan P, Squires RH, Strauss K, Soltys K, Mazariegos G, Squires JE. Hepatic Parenchymal Injury in Crigler-Najjar Type I. J Pediatr Gastroenterol Nutr. 2018 04; 66(4):588-594. 
- 
								Strauss KA, Robinson DL, Vreman HJ, Puffenberger EG, Hart G, Morton DH. Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr. 2006 May; 165(5):306-19.